$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 29,612 | 0 | 43,515 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 3,911 | 0 | 3,911 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 35,149 | 0 | 35,149 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.76 | 656 | 33,955 | 4,128 | 4.8 K to 4.1 K (-13.71 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 1,722 | 0 | 4,784 | 3.1 K to 4.8 K (+56.24 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.76 | 15,893 | 822,622 | 51,733 | 67.6 K to 51.7 K (-23.50 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 29,612 | 0 | 67,626 | 38 K to 67.6 K (+77.90 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Option Exercise | M | 0.00 | 6,985 | 0 | 10,703 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Option Exercise | A | 0.00 | 12,916 | 0 | 12,916 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Option Exercise | A | 53.22 | 30,000 | 1,596,600 | 30,000 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Sell | S | 51.76 | 2,821 | 146,015 | 15,783 | 18.6 K to 15.8 K (-15.16 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | COO | Buy | M | 0.00 | 6,985 | 0 | 18,604 | 11.6 K to 18.6 K (+60.12 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,000 | 10,820 | 7,904 | |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 36,642 | |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.01 | 1,000 | 52,010 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,000 | 10,820 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.01 | 10,000 | 520,100 | 38,014 | 48 K to 38 K (-20.83 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 48,014 | 38 K to 48 K (+26.31 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,096 | 11,859 | 8,904 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 904 | 6,554 | 0 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 20,000 | 293,800 | 46,642 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.02 | 1,096 | 54,822 | 3,062 | 4.2 K to 3.1 K (-26.36 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,096 | 11,859 | 4,158 | 3.1 K to 4.2 K (+35.79 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.71 | 904 | 44,938 | 3,062 | 4 K to 3.1 K (-22.79 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 904 | 6,554 | 3,966 | 3.1 K to 4 K (+29.52 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.02 | 20,000 | 1,000,400 | 38,014 | 58 K to 38 K (-34.47 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 20,000 | 293,800 | 58,014 | 38 K to 58 K (+52.61 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | A | 49.25 | 103,575 | 5,101,069 | 103,575 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | J | 42.76 | 86 | 3,677 | 25,827 | 25.7 K to 25.8 K (+0.33 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 49.25 | 54,638 | 2,690,922 | 54,638 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | J | 42.76 | 53 | 2,266 | 10,486 | 10.4 K to 10.5 K (+0.51 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Option Exercise | A | 49.25 | 58,125 | 2,862,656 | 58,125 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 50.00 | 163 | 8,150 | 11,619 | 11.8 K to 11.6 K (-1.38 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | J | 42.76 | 156 | 6,670 | 11,782 | 11.6 K to 11.8 K (+1.34 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 49.25 | 54,619 | 2,689,986 | 54,619 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 42.76 | 100 | 4,276 | 10,492 | 10.4 K to 10.5 K (+0.96 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 49.25 | 58,125 | 2,862,656 | 58,125 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 42.76 | 320 | 13,682 | 12,671 | 12.4 K to 12.7 K (+2.59 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 49.25 | 17,603 | 866,948 | 17,603 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 49.25 | 158,175 | 7,790,119 | 158,175 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Option Exercise | A | 49.25 | 58,125 | 2,862,656 | 58,125 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 42.76 | 491 | 20,993 | 5,760 | 5.3 K to 5.8 K (+9.32 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 49.25 | 54,619 | 2,689,986 | 54,619 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 42.76 | 106 | 4,532 | 15,147 | 15 K to 15.1 K (+0.70 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 28.47 | 3,000 | 85,410 | 0 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 50.56 | 3,000 | 151,680 | 9,939 | 12.9 K to 9.9 K (-23.19 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 28.47 | 3,000 | 85,410 | 12,939 | 9.9 K to 12.9 K (+30.18 %) |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 28.47 | 3,000 | 85,410 | 3,000 | |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 51.69 | 3,000 | 155,070 | 9,939 | 12.9 K to 9.9 K (-23.19 %) |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 28.47 | 3,000 | 85,410 | 12,939 | 9.9 K to 12.9 K (+30.18 %) |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.29 | 5,000 | 51,450 | 0 | |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 52.55 | 5,000 | 262,750 | 10,392 | 15.4 K to 10.4 K (-32.48 %) |
| Dec 19 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.29 | 5,000 | 51,450 | 15,392 | 10.4 K to 15.4 K (+48.11 %) |
| Dec 06 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.29 | 4,000 | 41,160 | 5,000 | |
| Dec 06 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 57.00 | 4,000 | 228,000 | 10,392 | 14.4 K to 10.4 K (-27.79 %) |
| Dec 06 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.29 | 4,000 | 41,160 | 14,392 | 10.4 K to 14.4 K (+38.49 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.29 | 6,000 | 61,740 | 9,000 | |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 53.02 | 6,000 | 318,120 | 10,392 | 16.4 K to 10.4 K (-36.60 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.29 | 6,000 | 61,740 | 16,392 | 10.4 K to 16.4 K (+57.74 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 28.47 | 3,000 | 85,410 | 6,000 | |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 53.55 | 3,000 | 160,650 | 9,939 | 12.9 K to 9.9 K (-23.19 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 28.47 | 3,000 | 85,410 | 12,939 | 9.9 K to 12.9 K (+30.18 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 1,000 | 10,820 | 700 | |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 55.50 | 1,000 | 55,500 | 10,433 | 11.4 K to 10.4 K (-8.75 %) |
| Dec 01 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 1,000 | 10,820 | 11,433 | 10.4 K to 11.4 K (+9.58 %) |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.29 | 7,000 | 72,030 | 15,000 | |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 54.35 | 7,000 | 380,450 | 10,392 | 17.4 K to 10.4 K (-40.25 %) |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 10.29 | 7,000 | 72,030 | 17,392 | 10.4 K to 17.4 K (+67.36 %) |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 12.94 | 2,812 | 36,387 | 0 | |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 28.47 | 2,250 | 64,058 | 9,000 | |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 12.94 | 2,812 | 36,387 | 9,939 | 7.1 K to 9.9 K (+39.46 %) |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 53.56 | 2,250 | 120,510 | 7,127 | 9.4 K to 7.1 K (-23.99 %) |
| Nov 17 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 28.47 | 2,250 | 64,058 | 9,377 | 7.1 K to 9.4 K (+31.57 %) |
| Nov 14 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 55.39 | 3,000 | 166,170 | 7,127 | 10.1 K to 7.1 K (-29.62 %) |
| Nov 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 1,000 | 10,820 | 1,700 | |
| Nov 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 58.35 | 1,000 | 58,350 | 10,433 | 11.4 K to 10.4 K (-8.75 %) |
| Nov 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 1,000 | 10,820 | 11,433 | 10.4 K to 11.4 K (+9.58 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 10.29 | 12,250 | 126,053 | 0 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 65.00 | 12,250 | 796,250 | 15,041 | 27.3 K to 15 K (-44.89 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 10.29 | 12,250 | 126,053 | 27,291 | 15 K to 27.3 K (+81.44 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 39.87 | 8,333 | 332,237 | 74,167 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 14.69 | 7,785 | 114,362 | 0 | |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 65.00 | 8,333 | 541,645 | 25,741 | 34.1 K to 25.7 K (-24.46 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 39.87 | 8,333 | 332,237 | 34,074 | 25.7 K to 34.1 K (+32.37 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 65.00 | 7,785 | 506,025 | 25,741 | 33.5 K to 25.7 K (-23.22 %) |
| Oct 20 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 14.69 | 7,785 | 114,362 | 33,526 | 25.7 K to 33.5 K (+30.24 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 904 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 66,642 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 1,500 | 89,190 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 15,000 | 891,900 | 38,014 | 53 K to 38 K (-28.29 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 7.25 | 7,035 | 51,004 | 0 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 10.29 | 426 | 4,384 | 0 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 7,035 | 422,100 | 12,351 | 19.4 K to 12.4 K (-36.29 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 7.25 | 7,035 | 51,004 | 19,386 | 12.4 K to 19.4 K (+56.96 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 426 | 25,560 | 12,351 | 12.8 K to 12.4 K (-3.33 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 10.29 | 426 | 4,384 | 12,777 | 12.4 K to 12.8 K (+3.45 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 807 | 48,420 | 12,351 | 13.2 K to 12.4 K (-6.13 %) |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 800 | 8,656 | 2,700 | |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 7.25 | 200 | 1,450 | 0 | |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 55.00 | 800 | 44,000 | 10,433 | 11.2 K to 10.4 K (-7.12 %) |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 800 | 8,656 | 11,233 | 10.4 K to 11.2 K (+7.67 %) |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 55.00 | 200 | 11,000 | 10,433 | 10.6 K to 10.4 K (-1.88 %) |
| Oct 06 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 7.25 | 200 | 1,450 | 10,633 | 10.4 K to 10.6 K (+1.92 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,000 | 7,250 | 2,404 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 81,642 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 3,404 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 91,642 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.25 | 500 | 27,125 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.20 | 500 | 27,100 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.25 | 5,000 | 271,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.20 | 5,000 | 271,000 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.50 | 500 | 26,250 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.05 | 500 | 26,025 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.45 | 500 | 25,725 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.50 | 5,000 | 262,500 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.05 | 5,000 | 260,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.45 | 5,000 | 257,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Option Exercise | M | 7.25 | 800 | 5,800 | 200 | |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Option Exercise | M | 7.25 | 200 | 1,450 | 1,000 | |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Sell | S | 55.00 | 800 | 44,000 | 10,433 | 11.2 K to 10.4 K (-7.12 %) |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Buy | M | 7.25 | 800 | 5,800 | 11,233 | 10.4 K to 11.2 K (+7.67 %) |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Sell | S | 55.00 | 200 | 11,000 | 10,433 | 10.6 K to 10.4 K (-1.88 %) |
| Sep 07 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal and Gene ... | Buy | M | 7.25 | 200 | 1,450 | 10,633 | 10.4 K to 10.6 K (+1.92 %) |
| Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 10.29 | 10,000 | 102,900 | 12,250 | |
| Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 59.29 | 10,000 | 592,900 | 15,041 | 25 K to 15 K (-39.93 %) |
| Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 10.29 | 10,000 | 102,900 | 25,041 | 15 K to 25 K (+66.48 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,000 | 7,250 | 4,904 | |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 106,642 | |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 1,000 | 55,350 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,000 | 7,250 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 10,000 | 553,500 | 38,014 | 48 K to 38 K (-20.83 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 48,014 | 38 K to 48 K (+26.31 %) |
| Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 28,884,540 | 0 | 0 | |
| Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 8.00 | 3,125,000 | 25,000,000 | 45,447,879 | 42.3 M to 45.4 M (+7.38 %) |
| Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 13,438,339 | 0 | 42,322,879 | 28.9 M to 42.3 M (+46.52 %) |
| Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 28,884,540 | 0 | 28,884,540 | 0 to 28.9 M |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 5,904 |